Academic Journal
Q1Journal of Diabetes Investigation
About Journal of Diabetes Investigation
Journal of Diabetes Investigation is a scholarly journal published by John Wiley and Sons Inc. SCImago 2025 lists it in Q1, with an SJR of 1.048 and H-index of 82.
Coverage: 2010-2026. Research categories: Medicine (miscellaneous) (Q1); Endocrinology, Diabetes and Metabolism (Q2); Internal Medicine (Q2).
Verified field sources
- Editor(s): Nigishi Hotta (Editor) — Official source; checked 2026-10-03. Editorial leadership listed under Edited By on the Wiley journal homepage; publisher role retained without assuming Editor-in-Chief.
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-17. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Diabetes Treatment and Management; Diabetes, Cardiovascular Risks, and Lipoproteins; Diabetes Management and Research; Pancreatic function and diabetes; Diabetes and associated disorders; Metabolism, Diabetes, and Cancer.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Renal glycogen handling in diabetes: A narrative review of diabetic kidney disease pathogenesis
Deenadhayalan Ashok, Poornima Ajay Manjrekar, Bhushan Chandrahasa Shetty, Sujina Simon Sailet et al.
2026-10-01 · DOI: 10.1111/jdi.70448Issue Information
2026-10 · DOI: 10.1111/jdi.70340Exploring the associations of overweight and obesity with pregnancy outcomes in type 1 and type 2 diabetes: An Australian retrospective cohort study
Xi May Zhen, Glynis Ross, Amanda Gauld, Arianne Sweeting et al.
2026-10-01 · DOI: 10.1111/jdi.70440Erythritol and metabolic dysfunction‐associated steatotic liver disease: A sweet friend, bitter foe, or reliable fellow traveler?
Kelly Hiu‐Ching Wong, David Tak‐Wai Lui, Chi‐Ho Lee
2026-09-29 · DOI: 10.1111/jdi.70453Circulating miR ‐342‐3p as a biomarker for diagnosing gestational diabetes mellitus and predicting adverse perinatal outcomes: A retrospective cohort study
Kangjun Yu, Sanqiang Niu, Hai Liang
2026-09-28 · DOI: 10.1111/jdi.70437Comparison of three gestational weight gain guidelines for adverse pregnancy outcomes in Chinese women with gestational diabetes: A cohort study
Shuang Zhang, Weiqin Li, Nan Li, Jia Guo et al.
2026-09-28 · DOI: 10.1111/jdi.70439Metabolic health, independent of body mass index, is associated with mortality risk in type 1 diabetes
Jung A Kim, Jimi Choi, Kyeong Jin Kim, Soo Myoung Shin et al.
2026-09-28 · DOI: 10.1111/jdi.70457M1 macrophage‐derived exosomes aggravate diabetic nephropathy by regulating the WTAP / S1PR2 axis
Lei Li, Hongmei Liu, Yu Mao, Huanhuan Wang et al.
2026-09-26 · DOI: 10.1111/jdi.70446Clinical characteristics and disease progression of typical adult‐onset type 1 diabetes and insulin‐dependent latent autoimmune diabetes in adults
Chanoknan Luksameejaroenchai, Thanida Tangjarusritaratorn, Lukana Preechasuk
2026-09-25 · DOI: 10.1111/jdi.70449Linagliptin increases the expression of LRP2 independent of Nrf2 in streptozotocin‐induced diabetic mice
Suratsawadee Promsuwan, Yumi Takiyama, Takao Takiyama, Yuri Takiyama et al.
2026-09-25 · DOI: 10.1111/jdi.70454Effect of pemafibrate on LDL ‐cholesterol properties in type 2 diabetes and hypertriglyceridemia by lipid management status: PARM ‐ T2D post hoc analysis
Hiroya Kitsunai, Kenichi Kito, Kazuno Omori, Kyu Yong Cho et al.
2026-09-25 · DOI: 10.1111/jdi.70456Glycated albumin: An old yet new biomarker in people with diabetes and the potential for novel applications
Masakazu Aihara, Naoto Kubota
2026-09-24 · DOI: 10.1111/jdi.70447Giant abdominal hematoma from injection into an insulin ball during dual antithrombotic and corticosteroid therapy
Yasuhiro Tanji, Hiroshi Komamura, Takashi Mita, Shojiro Sawada et al.
2026-09-24 · DOI: 10.1111/jdi.70455Association of atherogenic index of plasma with gestational diabetes mellitus and birth weight outcomes, and the mediating role of blood glucose
Doudou Zhao, Yanfang Song, Nan Li, Yu Zhang et al.
2026-09-24 · DOI: 10.1111/jdi.70452Comment on “Frailty and low body mass index as key determinants of sodium–glucose cotransporter 2 inhibitor‐specific adverse event‐related discontinuation in adults aged ≥75 years: A multicenter real‐world retrospective cohort study”
Jinmao Dai, Xiaohu Ma, Xiao Lei
2026-09-23 · DOI: 10.1111/jdi.70444Beyond global diabetes distress: What does PAID capture in type 1 diabetes?
Shinichiro M. Koga
2026-09-22 · DOI: 10.1111/jdi.70451Beyond PAID ≥40: Preserving the clinical meaning of diabetes distress in type 1 diabetes
Shinichiro M. Koga
2026-09-22 · DOI: 10.1111/jdi.70442A pitfall in the evaluation of Sampson‐estimated small dense LDL cholesterol in metabolic disorders: Is it equivalent to directly measured sdLDL ‐C?
Tsutomu Hirano
2026-09-21 · DOI: 10.1111/jdi.70450Long‐term effects of tofogliflozin on renal function in patients with type 2 diabetes: A retrospective multicenter study
Natsuko Shinagawa, Hiroshi Okada, Junya Hironaka, Shinta Yamamoto et al.
2026-09-19 · DOI: 10.1111/jdi.70445Reviews
Community Reviews
Version History
October 2, 2026 at 8:24 pm
October 2, 2026